{"entity":{"type":"insider","cik":"0001699022","url":"/insider/0001699022","json_url":"/insider/0001699022.json","name":"Kling Douglas F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":9,"first":"2025-01-29","last":"2025-07-17","span_basis":"filed_date"},"name_variants":[{"name":"Kling Douglas F","source":"filing","n_filings":9,"first_seen":"2025-01-29","last_seen":"2025-07-17"}],"transactions":[{"id":4378420,"accession":"0000950170-25-096665","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-096665","line_url":"/filing/0000950170-25-096665#line-5","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51043.0,"shares_display":"51,043","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":1077007.3,"total_display":"1,077,007.30","total_whole":"1,077,007","shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-17","scope":"insider"},{"id":4378412,"accession":"0000950170-25-096665","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-096665","line_url":"/filing/0000950170-25-096665","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47569.0,"shares_display":"47,569","price_per_share":21.435131703420296,"price_display":"21.44","price_state":"stated","total_value":1019647.78,"total_display":"1,019,647.78","total_whole":"1,019,648","shares_owned_after":47544.0,"shares_owned_after_display":"47,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-17","scope":"insider","n_lines":2},{"id":4027806,"accession":"0000950170-25-087937","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-087937","line_url":"/filing/0000950170-25-087937","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":19.2914104,"price_display":"19.29","price_state":"stated","total_value":1929141.04,"total_display":"1,929,141.04","total_whole":"1,929,141","shares_owned_after":62109.0,"shares_owned_after_display":"62,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider","n_lines":2},{"id":4713804,"accession":"0000950170-25-074463","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-074463","line_url":"/filing/0000950170-25-074463#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4165064,"accession":"0000950170-25-055612","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-055612","line_url":"/filing/0000950170-25-055612#line-3","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99090.0,"shares_display":"99,090","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44910.0,"shares_owned_after_display":"44,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-15","filed_date":"2025-04-17","scope":"insider"},{"id":4165053,"accession":"0000950170-25-055612","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-055612","line_url":"/filing/0000950170-25-055612#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-15","filed_date":"2025-04-17","scope":"insider"},{"id":4713120,"accession":"0000950170-25-046943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-046943","line_url":"/filing/0000950170-25-046943#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16539.0,"shares_display":"16,539","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-28","scope":"insider"},{"id":4872784,"accession":"0000950170-25-042176","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-042176","line_url":"/filing/0000950170-25-042176#line-3","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":4494820,"accession":"0000950170-25-024322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-024322","line_url":"/filing/0000950170-25-024322#line-4","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9218.0,"shares_display":"9,218","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-20","scope":"insider"},{"id":4494811,"accession":"0000950170-25-024322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-024322","line_url":"/filing/0000950170-25-024322#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90782.0,"shares_display":"90,782","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-20","scope":"insider"},{"id":4130529,"accession":"0000950170-25-011854","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-011854","line_url":"/filing/0000950170-25-011854#line-5","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8914.0,"shares_display":"8,914","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":4130526,"accession":"0000950170-25-011854","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-011854","line_url":"/filing/0000950170-25-011854#line-4","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4664.0,"shares_display":"4,664","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":52914.0,"shares_owned_after_display":"52,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":4130515,"accession":"0000950170-25-011854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-011854","line_url":"/filing/0000950170-25-011854#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56863.0,"shares_display":"56,863","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-31","scope":"insider"},{"id":4130396,"accession":"0000950170-25-010575","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-010575","line_url":"/filing/0000950170-25-010575#line-6","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20237.0,"shares_display":"20,237","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":49148.0,"shares_owned_after_display":"49,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":4130391,"accession":"0000950170-25-010575","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-010575","line_url":"/filing/0000950170-25-010575#line-5","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5148.0,"shares_display":"5,148","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":4130366,"accession":"0000950170-25-010575","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-010575","line_url":"/filing/0000950170-25-010575#line-3","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80359.0,"shares_display":"80,359","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":67815.0,"shares_owned_after_display":"67,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":4130362,"accession":"0000950170-25-010575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-010575","line_url":"/filing/0000950170-25-010575#line-2","is_derivative":false,"issuer_cik":"0001699022","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001699022","owner_cik":"0001699022","owner_name":"Kling Douglas F","owner_display_name":"Kling Douglas F","owner_url":"/insider/0001699022","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23815.0,"shares_display":"23,815","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001936258","name":"NewAmsterdam Pharma Co N.V.","url":"/issuer/0001936258","role":"Officer (Chief Operating Officer)","n_filings":9,"first_seen":"2025-01-29","last_seen":"2025-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001699022","retrieved_at":"2026-08-26T05:25:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}